Sebastian Wehle
Direttore/Membro del Consiglio presso TIGENIX NV
Posizioni attive di Sebastian Wehle
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| TIGENIX NV | Direttore/Membro del Consiglio | 15/06/2018 | - |
Storia della carriera di Sebastian Wehle
Precedenti posizioni note di Sebastian Wehle
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| TAKEDA PHARMACEUTICAL COMPANY LIMITED | Corporate Officer/Principal | - | - |
Formazione di Sebastian Wehle
| University of Kiel | Doctorate Degree |
Statistiche
Distribuzione geografica
| Belgio | 2 |
| Giappone | 2 |
| Germania | 2 |
Posizioni
| Director/Board Member | 1 |
| Corporate Officer/Principal | 1 |
| Doctorate Degree | 1 |
Settori
| Health Technology | 3 |
| Consumer Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| TAKEDA PHARMACEUTICAL COMPANY LIMITED | Health Technology |
| Aziende private | 1 |
|---|---|
TiGenix NV
 TiGenix NV Medical SpecialtiesHealth Technology TiGenix NV engages in the research, development, and commercialization of biopharmaceutical products. The firm's portfolio includes allogeneic adipose-derived stem cells and allogeneic cardiac stem cells. It intends to treat Crohn's disease, sepsis, autoimmune disorders, acute myocardial infarction, and chronic cardiovascular indication. The company was founded by Gil Beyen and Frank P. Luyten on February 21, 2000 and is headquartered in Leuven, Belgium. | Health Technology |
- Borsa valori
- Insiders
- Sebastian Wehle
- Esperienza
